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Information, behaviors, and technologies spread when people interact. Understanding these
interactions is critical for achieving the greatest diffusion of public interventions. Yet, little is
known about the performance of starting points (seed nodes) for diffusion. We track routine
mass drug administration—the large-scale distribution of deworming drugs—in Uganda. We
observe friendship networks, socioeconomic factors, and treatment delivery outcomes for
16,357 individuals in 3491 households of 17 rural villages. Each village has two community
medicine distributors (CMDs), who are the seed nodes and responsible for administering
treatments. Here, we show that CMDs with tightly knit (clustered) friendship connections
achieve the greatest reach and speed of treatment coverage. Importantly, we demonstrate
that clustering predicts diffusion through social networks when spreading relies on contact
with seed nodes while centrality is unrelated to diffusion. Clustering should be considered
when selecting seed nodes for large-scale treatment campaigns.
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The social connections between people inﬂuence the spreadof information, behaviors, and technologies1–5. Under-standing the structure of social networks is essential for
targeting beneﬁciaries and improving the diffusion of public
interventions6. A key policy challenge concerns how best
to identify and to evaluate the performance of starting points
(seed nodes) for interventions. Seed nodes in social networks are
predominantly selected and targeted based on their centrality7–9.
Centrality is a set of measurements that describes the connectivity
and embeddedness of a node in a network and is widely viewed as
a measure of power and inﬂuence in social systems10. High
centrality of seed nodes promotes simple epidemic spreading,
which is the most common model of diffusion5,11. In these
models, each additional social contact increases the probability of
information transmission and diffusion unfolds along the shortest
paths in a network12,13. Long, weak links that bridge otherwise
disconnected groups facilitate diffusion14,15, but this simple
epidemic spreading5,11 does not account for possible brokerage
properties of bridges in social networks16. On the other hand, the
reach of seed nodes has been shown to rely on the topology of the
network3,4,17,18. Inﬂuential seed nodes may group together3
or belong to the core of the network17. Network topology is
particularly important in models of complex contagion19, where
repeated exposure and social reinforcement are needed before an
individual partakes in an intervention. In contrast to simple
epidemic models, the probability of information or technologies
spreading is zero until an exposure threshold is met for the
recipient12,13 and diffusion tends to travel along short densely
clustered ties1,2,4,19,20,21,22. Clustering is one indicator of network
transitivity and is pervasive in social networks23. Transitivity
implies that two nodes are connected if they share a network
neighbor24. In friendship networks, clustering exists if two friends
of the node of interest also are friends. Importantly, in simple
epidemic models, high network transitivity causes redundancy
and slows spreading, whereas in complex contagion models, this
redundancy is required for diffusion to occur.
It is not known whether centrality (simple epidemic) or tran-
sitivity (complex contagion) is relevant for evaluating seed node
performance in real-world contexts that require repeated contact
with seed nodes. Diffusion that relies on repeated contact with
seed nodes applies to a number of important social interventions
in rural poor areas of low-income countries. For example, the
distribution of bed nets, vaccines, and deworming treatments in
low-income countries depends on a small set of locally trained
individuals and their repeated contact with other community
members25,26. These seed nodes are tasked with approaching all
households at speciﬁed time points to administer medicines as
opposed to relying on a chance probability of meeting. Thus far,
the study of seed nodes in social networks has assumed that after
the initial subset of individuals are informed by the seed nodes,
there is no need for subsequent individuals to directly contact
seed nodes. An important open question remains: what deter-
mines spreading when seed nodes must directly contact potential
recipients? Herein, we address this question by examining the
diffusion of treatment through mass drug administration (MDA)
and village friendship networks.
MDA is the community-wide distribution of preventive
chemotherapies to treat human parasitic worms26. Treatments
are provided at no ﬁnancial cost and are safely administered to
infected and uninfected individuals. Annual or biannual MDA is
necessary due to rapid reinfection. In sub-Saharan Africa,
over 633 million people require preventive chemotherapy, yet
only 1/3rd of these individuals are approached for treatment
through MDA27. Each village in our study area in Mayuge Dis-
trict, Uganda has two community medicine distributors (CMDs).
These individuals are unpaid volunteers28, who receive only a
nominal reimbursement for transport to training. CMDs are
trained and retrained annually to treat all eligible individuals in
their village. In 2013, an undisturbed, routine round of MDA was
tracked for 1 month. This time frame enabled comparisons across
study villages, minimized recall bias for treatment coverage out-
comes, and was within national treatment schedules. Data were
collected in 17 villages for 16,357 individuals within 3491 homes.
Friendship networks were deﬁned at the household level because
CMDs were instructed by the local government to move from
home to home. An undirected edge between two households was
generated if a member of one household named any member of
another household as a close friend. The advantages of studying
close friendship networks for MDA include the lack of predeﬁned
roles and network positions of CMDs, as well as an approxima-
tion of static networks in our rural villages. A static network has
edges that do not change frequently (in this case, close friendships
remained over several years).
Our study design avoids several potential sources of bias and
provides a real-world environment to examine seed node
performance. MDA for intestinal schistosomiasis and soil-
transmitted helminths began in our study area in 200326.
Accordingly, the target population was familiar with MDA, social
learning was unnecessary, and most individuals would comply
with treatment if offered in this context29. Before the ﬁrst round
of MDA in our study area, government health workers visited
communities and asked villagers to meet and select CMDs30. This
context is the real setting that public interventions must be
assessed. Selecting any person, e.g., via random assignment, to be
a seed node often is not possible. To integrate stakeholders of
interventions, government or non-governmental organizations
utilize individuals selected by their communities7,26. Researchers
and village members knew the starting points for information and
treatment diffusion. The current CMDs had been active for
several years and were reminded of their duties during annual
retraining. CMDs were well acquainted with their responsibilities
and identiﬁable by other villagers. Apart from CMDs, eligible
individuals had no access to MDA pills or information
about drug availability outside of their village. Nationally led
information campaigns and school-based distribution had not
commenced during the study. Hence, information on drug
availability was initially monopolized by CMDs. Per routine
MDA procedures, CMDs received training and drugs for MDA
outside of their village. Treatments were only available from
CMDs within the village. Nearby health centers and primary
schools had not received drugs during the study (due to delays by
the national control program) and CMDs did not leave pills with
treated households to pass onwards to untreated households.
Also, CMDs had knowledge of and registered all households prior
to the start of distribution and were provided a sufﬁcient number
of pills to treat all individuals in their village.
The treatment coverage achieved by CMDs was examined. In
each village, we measured coverage as the percentage of eligible
households that were visited and offered treatment by CMDs.
Speciﬁcally, household coverage (binary) was deﬁned as at least
one eligible person in the home being approached by CMDs and
offered at least one treatment through MDA. Positive household
coverage included eligible individuals who were visited by CMDs
and refused treatment. Treatment coverage measured the delivery
of medicines. Coverage was studied to isolate CMD performance
(as opposed to the ingestion of pills; compliance) simply because
the choice to offer medicine to eligible individuals rests with
the CMD, whereas compliance with the offered treatment is
dependent on the ﬁnal decision of the recipient. To identify
what factors determined the total reach and speed of household
coverage in each village, we assessed measures of centrality10 and
local transitivity31 of seed nodes. These network indicators were
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normalized to account for variation in village/network size and
then averaged for the two CMDs in each village. For the speed of
diffusion, the number of days required for CMDs to reach 50%
household coverage was examined. This 50% target is a highly
conservative measure of World Health Organization (WHO)
guidelines, which recommend at least 75% coverage of all school-
aged children as a feasible goal25. The 50% target was chosen to
include as many villages as possible while remaining as close as
possible to actual WHO goals. We ﬁnd that clustering predicts
the reach and speed of drug delivery, while centrality is unrelated
to diffusion. Clustering should be considered when selecting seed
nodes for large-scale treatment campaigns.
Results
Network completeness and external consistency. Complete,
sociocentric networks were constructed that included a total of
3436 nodes and 16,155 edges (Supplementary Table 1). In all
ID 1 ID 2 ID 3
ID 4 ID 5 ID 6
ID 7 ID 8 ID 9
ID 12ID 11ID 10
ID 13 ID 14 ID 15
ID 16 ID 17
Fig. 1 Community medicine distributors in full village friendship networks. Figure 1 presents friendship networks for each of the 17 study villages.
The numbers above each graph are the village IDs. The red nodes represent the location of the community medicine distributors (CMDs) in the network.
In all villages, CMDs are well connected and embedded in the center of their village friendship network. Full descriptions, including the number of nodes
and edges, are provided in Supplementary Table 1
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villages, if the household did not belong to the main connected
component, the household was an isolate (belonged to no other
network components). Across the 17 villages, only 55 households
were not in the main component and 87 households refused to
participate in the survey. Therefore, 96.03% (3436/3578) of
all households available at the time of survey were included
in the main component of their village network. Only 4.95%
(859/17347) of names provided in all villages for friendship
connections—the maximum possible edges, including self-loops
and multi-edges—were not matched; a remarkable 99.04%
(16200/16357) of individuals who were recorded in household
surveys were in a household included in a main network
component. No upward bias, which would entail individuals
naming as many outgoing connections as possible irrespective
of friendship status, was observed. Only 4.83% (166/3436)
of households included in the friendship networks listed the
maximum of 10 outgoing connections.
The networks studied here share structural properties with a
wide range of complex physical, biological, and social systems
(Supplementary Table 1 and Supplementary Fig. 1)32. High
centrality was observed for CMDs (Fig. 1), who were selected by
members of their village. The degree of each CMD varied
considerably and ranged from 7 to 80. However, CMD degree was
greater, in every village, than the average degree of all households.
As shown in Fig. 2, wide variation was observed in the local
transitivity of connections among CMDs and their friends. The
clustering coefﬁcient of CMDs varied greatly from star-shaped
ego networks (clustering coeff. = 0; village ID 1) to highly
transitive ego networks (clustering coeff.= 0.429; village ID 17).
See Supplementary Table 2 for a summary of CMD network
statistics.
Treatment coverage achieved. In the study villages,
household coverage varied from 23.14 to 93.53% (Supplementary
Tables 3, 4). Overall, approximately one-third (1011/3415) of
households were not approached by CMDs during 1 month of
MDA. There was little or no informational diffusion about drug
availability between households that were visited by CMDs and
households that were never approached for treatment. When
non-recipients were asked if they heard that drugs were available
ID 1 ID 2 ID 3
ID 4 ID 5 ID 6
ID 7 ID 8 ID 9
ID 10 ID 11 ID 12
ID 13 ID 14 ID 15
ID 16 ID 17
Fig. 2 Egocentric networks of community medicine distributors. Figure 2 presents 34 egocentric networks where the ego of interest is the community
medicine distributor (CMD). There were two CMDs per village and the numbers above the graphs correspond to the village ID. These plots are not ordered
by any descriptive or network characteristics. The subgraphs were extracted from full village networks and each neighbor of the CMD and all
corresponding edges between those neighbors were included. Vertices in these networks are households and edges indicate friendship ties between
households. The CMD household is the red vertex in the center of the subgraph. Wide variation in clustering—the frequency that friends of CMDs also
were friends—is easily observable across villages. For example, the star and star-like ego networks in village ID 1 have clustering coefﬁcients of 0 and 0.067
and the ego networks of village ID 7 have clustering coefﬁcients of 0.168 and 0.191
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during the 1-month distribution, 85.06% (860/1011) of house-
holds that were not offered medicines by CMDs had no eligible
person in the home that knew drugs were available in the village.
These households constituted 25.18% (860/3415) of all house-
holds with at least one person who was eligible for treatment
through MDA.
Clustering, due to its positive correlation with the number of
households visited by CMDs, was associated with increased
treatment coverage. The frequency that friends of CMDs were
also friends (clustering) was positively related to household
coverage (p value= 0.011) (Table 1). CMDs in the 90th percentile
of clustering were estimated to have approached 9.32% (p value
< 0.001) more households in their village, achieving on average
78.1% household coverage, when compared to CMDs in the 10th
percentile of clustering who reached an estimated 68.8% of
households. Hence, clustering was associated with a village
realizing the 75% coverage target set by the WHO25. This target is
an approximation of the treatment coverage needed to control
morbidity attributable to helminthic infections. Our results are
consistent with ﬁndings from artiﬁcially constructed online
networks. Centola shows how global (network-level) clustering
is efﬁcient for the spread of social behaviors1. Global (village
level) clustering was associated with average CMD clustering
(Supplementary Fig. 2) and household coverage (Supplementary
Table 5). Though, when global and CMD clustering were
compared in stepwise regressions, using an alpha-to-enter of
0.15, only average CMD clustering was retained as a signiﬁcant
predictor of household coverage.
Although CMDs with high clustering achieved the greatest
household coverage, the number or completeness of connections
among their friends was not informative. The proportion of
possible edges (density) was borderline insigniﬁcant (p value=
0.055) and the fraction of reciprocated ties among friends of
CMDs was uncorrelated (p value >0.05) with household coverage.
Belonging to a well-connected group of friends was not associated
with household coverage; the largest degree shared among the
friends of CMDs (core number) was insigniﬁcant (p value >0.05).
There was no support (p value >0.05) that CMDs needed to
belong to a large set of households, where everyone was
completely connected to everyone else in the friend group, i.e.,
have a high clique number.
Social network analysis in low-income countries has relied on
centrality for guiding the selection of seed nodes8. For example, in
a project in India, seed nodes were selected non-randomly by a
non-governmental organization and used to spread information
about an innovation—microﬁnance7. The communication and
eigenvector centralities of these ﬁrst-informed seed nodes were
positively associated with the reach of diffusion, although which
seed nodes actually shared information was unknown. We found
no such relationship in our study. CMD centrality indicators,
which measured neighborhood size, connectivity, embeddedness,
and accessibility to other nodes, were unrelated (p value >0.05) to
household coverage. Our results suggest that being well connected
or embedded in a network may facilitate the diffusion of
innovations with simple epidemic spreading7, but was not
informative for the diffusion of a familiar technology, where
spreading relied on contact with seed nodes (our study). There is
experimental support for this inference from Honduras, where
well-connected nodes did not achieve greater diffusion of
multivitamins when compared to randomly selected nodes33.
We also ﬁnd no correlation of clustering with centrality
(Supplementary Table 6). Clustering as opposed to centrality
should be considered when selecting seed nodes for existing
technologies and diffusion processes that depend on repeated
contact with seed nodes.
Speed of treatment distribution. The speed of treatment
distribution was assessed by comparing the number of days
Table 1 Inﬂuence of CMD network properties on village treatment coverage
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required for each village to achieve 50% household coverage
(Fig. 3). Two of ﬁve villages (ID 7 and ID 17) that achieved
the highest household coverage were also among the ﬁve fastest
villages. The frequencies of households offered treatment against
the day of CMD visits are provided in Supplementary Table 7.
Three indicators of local transitivity were associated with the
speed of treatment distribution—clustering, reciprocity, and
density (Table 2). CMDs with tightly knit friends (high cluster-
ing) were more likely (p value= 0.015) to approach 50%
of households sooner than CMDs with friends who were not
connected (low clustering). The fraction of reciprocated edges in
the CMD ego networks was associated (p value= 0.045) with
faster diffusion of household coverage. CMDs with higher edge
density in their ego networks were more likely (p value= 0.013)
to achieve 50% household coverage in fewer days than CMDs
whose friends were less densely connected. These relationships
imply that increasing local transitivity for CMDs may halve the
distribution time to reach 50% household coverage in a 1-month
period of MDA. The predicted time to reach 50% household
coverage was 10.48–11.93 days shorter (p value <0.001) for
CMDs at the 90th percentiles of average clustering, reciprocity, or
density when compared to CMDs at the 10th percentiles of these
network properties. These results suggest that seed nodes are
most efﬁcient, with respect to diffusion speed, when located
within clusters34. This practical ﬁnding can help policymakers
conceptualize the time needed to reach targets when diffusion is
reliant on clustering. We ﬁnd that the delivery of medicines
occurs much slower than recommended by WHO guidelines,
which suggests that treatment coverage of 75% of individuals is a
feasible goal in routine schedules set by local governments for
MDA25. In our study region in Uganda, these routine schedules
aim to complete drug distribution within 2–3 weeks (Supple-
mentary Methods). Yet, during 1 month of MDA, only 64.71%
(11/17) and 25% (3/17) of villages had CMDs who approached,
respectively, 75% of households or 75% of eligible individuals for
at least one treatment.
The core and clique numbers of CMDs as well as several
indicators of CMD centrality were uncorrelated (p> 0.05) with
the number of days required to reach 50% household coverage.
All results remained when reanalyzed against the proportion of
eligible individuals offered treatment (Supplementary Table 8 and
Supplementary Fig. 3).
Robustness to confounders. We studied possible confounding
factors (Supplementary Table 9). Temporal clustering, which was
measured as the standard deviation of the day of drug receipt for
households connected to CMDs, was insigniﬁcant (p value >0.05)
for household coverage. Thus, the inﬂuence of clustered friends
on CMD performance cannot be attributed to CMDs quickly and
directly communicating with all of their friends about ongoing
MDA35. Differences in diffusion among villages were not simply
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Fig. 3 Time series of household treatment coverage. In Fig. 3, household coverage is the cumulative fraction of eligible households where at least one
eligible individual was offered at least one drug through mass drug administration. Information on the day of drug receipt was unavailable for individuals
refusing treatment. These noncompliers were excluded from the calculation of treatment delivery speed (see Supplementary Methods). To enable a
comparison with the reach of household coverage, the plots are ordered by household coverage achieved, which is stated in the graph titles. Household
coverage may differ from the graph maximum. Household coverage included noncompliers and individuals who were offered and accepted treatment but
did not remember the day of drug receipt. In parentheses, the village ID is presented. The dashed line represents 50% household treatment. Village ID 17,
which had a shorter distribution span than the other villages, was the smallest village of only 65 households. This village also approached 50% of
households in the ﬁrst day of distribution. As a robustness check, the speed analysis was repeated for individual coverage, which was the proportion of
eligible individuals offered treatment (Supplementary Fig. 3 and Supplementary Table 8). In this case, village ID 17 approached 50% of eligible individuals
on Day 7
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due to the lack of communication between CMDs. The CMDs,
who achieved the greatest diffusion, did not need to be close
friends. An edge (direct connection) between seed nodes was
insigniﬁcantly (p value >0.05) associated with household cover-
age. The maximum shortest path length (geodesic distance)
connecting two CMDs was three edges and variation in this small
social distance was uncorrelated (p value >0.05) with household
coverage. Incentives to conform36 or to receive ﬁnancial payment
were highly unlikely as CMDs were unpaid volunteers who were
trained to promote MDA. No apparent difference in the abilities
of CMDs to distribute treatment was observed. All CMDs were
better off with respect to socioeconomic status and network
position than the rest of their village (Supplementary Tables 3, 4)
and the capacity of CMDs, as measured by degree or closeness
centrality, was uncorrelated with diffusion (Tables 1, 2). Hence,
community selection successfully identiﬁes well-connected and
better-educated people to be CMDs, but can be improved by also
incorporating clustering into the selection criteria.
We also explored whether the presence of homophily—the
shared likeness among CMDs and their friends—confounded and
inﬂated effects of CMD network properties37,38. We found no
evidence (p value >0.05) that homophily affected the reach of
household coverage (Supplementary Table 9). All results of
temporal clustering, CMD friendship, and homophily remained
robust against village treatment distribution speed (Supplemen-
tary Table 10). Moreover, the shared likeness and personal
characteristics of CMDs in each village also did not affect our
results or CMD clustering, respectively (Supplementary
Tables 11–13).
Lastly, Fig. 4 and Supplementary Table 14 present the
association of village size, accessibility, and ecology with
treatment coverage and speed. The total number of households
was unrelated (p value >0.05) to the household coverage achieved
and was borderline insigniﬁcant (p value= 0.054) for how quickly
50% of households were approached. Moreover, the proportion of
total households directly connected to CMDs in the village
friendship network was uncorrelated (p value >0.05) with
household coverage and treatment delivery speed. Villages with
few households (e.g., IDs 9, 15) were not necessarily small with
respect to geographical spread (Supplementary Fig. 4). The
physical size of the village, which was measured as the furthest
distance in meters between two households (spatial diameter),
was unrelated (p value >0.05) to diffusion. Concerning village
accessibility, no correlation (p value >0.05) of household coverage
or treatment delivery speed with the average distance in meters
between two households or village ecology was observed. In
addition to moving from home to home to distribute treatments,
as instructed by the national program during training, 41.18%
(7/17) of villages had CMDs who also informed individuals to
come to their home to pick up treatments. This increased
availability or access to treatments was uncorrelated (p value
> 0.05) with diffusion.
Discussion
Seeding effective distribution of treatment by CMDs relies on
clustering. Strong ties among friends of CMDs were associated
with an increased rate and level that households were visited and
offered treatment by CMDs. Unlike simple epidemic processes
that require only one contact to propagate information, seed
nodes required constant reinforcement to engage in effective drug
distribution. Social reinforcement to deliver treatment is needed
for CMDs, who are volunteers, due to the costly investment of
time required to visit and revisit all households39. Ex-post focus
groups with CMDs and village leaders revealed one mechanism of
Table 2 Inﬂuence of CMD network properties on speed of treatment diffusion
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clustering that increased drug delivery by CMDs (Supplementary
Methods). Close-knit friends were better able to provide infor-
mation to the CMDs about problems in the community and
missed households. We isolated the mechanism of clustering
from other roles35,40 of social reinforcement such as ostracism of
poor-performing CMDs, an explanation that was dismissed by
focus group participants.
Clustered friends of CMDs were better able to provide social
reinforcement as the closure in the network structure facilitated
direct communication between the friends40. These ﬁndings are
consistent with models of complex contagion1,19,20. Our cluster-
ing result also extends and develops published empirical ﬁnd-
ings41,42, which show that local networks around women
determine contraceptive use in low-income countries, to the
diffusion of medicines targeting all individuals in a village.
Additional studies in other countries are recommended to
externally validate these ﬁndings and to further analyze causality.
Future treatment plans should consider clustering when
selecting seed nodes and designing interventions to improve
diffusion. Graphing complete sociocentric village networks, as we
did in this study, is an expensive and arduous task for MDA
programs in low-income countries. However, our observation
that clustering is associated with the diffusion of treatment sug-
gests that the whole village need not be graphed. Targeting
clustering is relatively simple, as only the direct connections are
needed for CMDs or other seed nodes (ego networks). To further
simplify measuring clustering in routine assessments by MDA
program managers, future research could investigate the accuracy
and applicability of proxy indicators for clustering. Such proxy
indicators may include CMDs’ perceived ego networks and
nominations of individuals with high clustering by village
members.
Clustering can guide public interventions for MDA.
MDA programs, in particular for onchocerciasis43–45, have
demonstrated success by utilizing kinship structures in rural
communities. The selection of CMDs by kinship has reduced
CMD attrition, increased treatment coverage, and held CMDs
accountable for providing health information. Additional work
should investigate the extent in which such social structures may
overlap with friendship networks. Friendship networks are
another social structure that can complement kinship and be used
to improve CMD selection. During the initial selection of seed
nodes, village-nominated CMDs can be surveyed to assess if their
friends are connected. The ﬁnal selection of CMDs can be
informed by how tightly knit the connections are among their
friends. In villages with established CMDs, interventions to
improve treatment coverage can focus on increasing clustering.
Joint social activities or shared tasks can be established for friends
of CMDs to foster connections within this group. These friends
may also be asked to serve as a feedback loop of information
to CMDs about community perceptions of ongoing problems
with drug delivery. This potential role of friends in monitoring
the village may partially alleviate opportunity costs that are
incurred by volunteer CMDs from time spent distributing med-
icines.28. Alternatively, additional seed nodes with high clustering
can be selected to assist existing CMDs with treatment distribu-
tion and to disseminate information to CMDs and the wider
community.
Methods
Ethics. This study was reviewed and approved by the Uganda National Council of
Science and Technology, the Ofﬁce of the President in Uganda, and the Cambridge
University Human Biological Research Ethics Committee. Informed consent was
obtained from all respondents and recorded on tablet computers preceding the
household interview. All village names have been replaced with village codes to
preclude the identiﬁcation of individuals in the study villages.
Participants and data source. On 1 November 2013, household surveys com-
menced in the 17 study villages following 1 month of undisturbed MDA. CMDs
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Fig. 4 Village size and accessibility against treatment outcomes. Household coverage is deﬁned as the proportion of households in the village where at
least one eligible person in the home was offered at least one treatment through mass drug administration. Treatment speed is deﬁned as the number of
days until community medicine distributors visited 50% of households. Within the one-month distribution period, 15/17 villages achieved 50% household
coverage. Supplementary Table 14 presents the regression results and signiﬁcance of the relationships shown in Fig. 4. a, b The village size, as measured
by the total households in the village, was not signiﬁcantly related to household coverage (p value= 0.077) and borderline insigniﬁcant for treatment
speed (p value= 0.054). c, d The average distance between any two households in each village was calculated in meters. There was no correlation
(p value >0.05) with household coverage or treatment speed and the average distance between households
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were not informed of these visits beforehand to avoid inﬂuencing distribution and
the surprise visits were explained as an effort to understand the efﬁcacy of the
national drug programs on infection prevalence. Households in each village were
approached for interview and information was collected on every person in the
home that was at least 1 year of age. The household head was interviewed and, if
married, a spouse also was asked to participate. Socioeconomic information and
treatment receipt outcomes were surveyed for every household member, and
network data were collected at the household level. Data were collected on a total of
16,357 individuals in 3491 households. Infants were not included in the household
list. Preliminary work, in February 2013, to understand naming conventions (how
children are named when born, how female names change when they marry, and
so on) showed that adults did not count individuals younger than 1 year as a
household member. Moreover, individuals younger than 1 year were ineligible for
any of the drugs that were distributed through MDA, per WHO guidelines46.
Treatment coverage outcomes. Treatment coverage was measured for all 16,357
participants by asking if praziquantel, albendazole, or ivermectin was offered to
them from CMDs within the past month. Three methods were used to facilitate the
recognition of the drugs. Photos (Supplementary Fig. 5) of each drug were shown
on tablet computers, detailed descriptions were provided, and the actual drugs were
handed to respondents to touch, see, and smell. If an individual stated they received
a drug, then a follow-up question asking which day in the past month the indi-
vidual received the drugs was asked (Supplementary Table 15). To assist indivi-
duals with understanding time, familiar events such as a school week, day of church
attendance, and so on were informally provided as examples of time reference
points. Directly observed treatment (DOT)47 is the standard procedure for all
neglected tropical diseases targeted by MDA in Uganda. In DOT, CMDs are
trained to assist and to observe an individual swallowing the offered medicines.
CMDs are retrained on DOT each year during training conducted by district health
personnel. Though quantitative evidence is unavailable to conﬁrm the enforcement
and monitoring of DOT, self-reported compliance (drug ingestion) suggests high
conformity to DOT. Over 88% (7358/8302) of 16,200 individuals in friendship
networks (see Supplementary Methods), who were offered medicine, swallowed the
drugs offered. Anecdotally, CMDs indicated that such ingestion was observed, i.e.,
DOT was used. However, the Ugandan national control program does not equate
the distribution of medicines to actual ingestion, a frequent assumption of global
MDA statistics. This inference is a result of anecdotal reports outside of our study
period of individuals convincing CMDs to deviate from DOT practices and to
allow them to swallow the medicines at another time.
Varying deﬁnitions of treatment coverage complicate comparisons of studies
across the MDA literature47–50. Our deﬁnition here is most similar to the WHO
recommended deﬁnition of surveyed coverage. However, the difference between
treatment coverage in this paper and the deﬁnition of surveyed coverage47,48 is that
treatment coverage here included individuals who refused to ingest pills. Our
indicator captured an important aspect of CMD performance, which is not the
targeted measurement of WHO deﬁnitions that focus on recipient outcomes. We
directly measured how often CMDs make available and offer medicines to eligible
individuals. This outcome would be underestimated if we relied on surveyed
coverage. For comparison, we recalculated household coverage as surveyed
coverage, i.e., measured household coverage as positive only when at least one
eligible individual in the home self-reported ingestion of drugs. This surveyed
coverage was nearly perfectly correlated with our outcome (Pearson’s r= 0.967,
p value < 0.001). Thus, our results can be compared to studies using surveyed
coverage.
Network construction. The nodes and edges in the network, respectively, were
households and friendship ties. An edge was generated between households if any
person in a household was named or had named any person in another household
as a close friend. A self-loop occurred when a household named someone within
their own home as a close friend. Households were instructed to name individuals
outside of their home. Accordingly, self-loops were ignored and only households
belonging to the main component were analyzed. Multiple connections (multi-
edges) in the same direction from one household to another household, e.g.,
naming multiple people from the same household, were measured as one edge. We
make the working assumption that villages are independent; though it is possible
some individuals may have friends in other villages in the study. The full set of
16,357 individuals in the 17 villages was used in the network construction. The
name generator was the following:
Please tell me the clan name ﬁrst then the second name of up to 10 people that
are very close friends to you. You should feel comfortable to turn to this person to
borrow tools for ﬁshing or farming without paying. A close friend is also someone
that you see frequently. Do not name anyone in your household. Provide the names
in the order of who is your closest friend ﬁrst. Only name people in your village.
Statistical analysis. Treatment coverage, which represented the performance of
CMDs, was analyzed using Stata v.13.1. Figure 5 presents the diffusion outcomes
for CMDs and an overview of the statistical analysis. Diffusion achieved by CMDs
was measured at the village level by examining the fraction of the village that was
offered treatment by CMDs and the speed at which treatment was distributed.
These variables, as deﬁned in the treatment coverage section of the Supplementary
Methods, were constructed for both households and individuals to capture dif-
ferent aspects of diffusion and to test the consistency of the results. Household
coverage, which measured if at least one eligible individual in the home was offered
treatment by CMDs, indicated if the CMD approached the home. Household
coverage was the focus of this paper. As a robustness check, individual coverage
also was examined. Individual coverage represented the proportion of eligible
individuals offered treatment by CMDs in a village. This variable may capture if a
CMD returned to a home to provide treatment to individuals who were not present
on the ﬁrst visit or to administer the second round of treatment (albendazole and
ivermectin). Topological characteristics of centrality and clustering for the CMD
households in the full village friendship network were used to explain diffusion in
robust51 fractional response models with Probit estimation52 and Poisson regres-
sions53. Additional robustness checks are provided in the Supplementary Methods
and Supplementary Tables 16–21.
Diffusion
Fraction treated Speed treated
Household HouseholdIndividual Individual
Network properties of 
community medicine distributor
Homophily
testing
Research
objective
Outcomes
Outcome
units
Predictors
Robustness
checks
Village size
and ecology
Fig. 5 Schematic of the statistical analysis. The main outcome of interest was diffusion. This outcome was measured as the maximum fraction of eligible
households or individuals offered treatment by community medicine distributors (CMDs) and the speed at which those households or individuals were
offered treatment. Speed measured which villages reached a speciﬁc level of treatment coverage and at which day in the distribution period. The network
characteristics of CMDs were the main predictors of interest. To understand why certain network indicators of CMDs may be associated with the diffusion
outcomes, robustness checks were conducted. The contribution of homophily to diffusion was assessed, i.e., the afﬁnity for treatment or shared factors that
may predict treatment coverage and are unrelated to network topology. The robustness checks also included examining village ecology, size, and physical
spread of households (in meters) against diffusion
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Data availability. All relevant data are available in the paper, Supplementary
Information, and on request from the corresponding authors.
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